PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 57 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | -70.5% | 11,991 | -62.8% | 0.00% | – |
| Q2 2020 | $44,000 | -38.0% | 32,247 | -48.3% | 0.00% | – |
| Q1 2020 | $71,000 | -60.8% | 62,341 | -21.5% | 0.00% | – |
| Q4 2019 | $181,000 | +2485.7% | 79,412 | +782.4% | 0.00% | – |
| Q3 2019 | $7,000 | -70.8% | 9,000 | -64.0% | 0.00% | – |
| Q2 2019 | $24,000 | -79.7% | 24,968 | -73.5% | 0.00% | – |
| Q1 2019 | $118,000 | +2260.0% | 94,101 | +4978.3% | 0.00% | – |
| Q2 2018 | $5,000 | – | 1,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,804,027 | $17,803,000 | 2.95% |
| HARBOURVEST PARTNERS LLC | 440,627 | $2,062,000 | 0.89% |
| NEA Management Company, LLC | 3,556,778 | $16,646,000 | 0.61% |
| Rock Springs Capital Management LP | 450,000 | $2,106,000 | 0.11% |
| Bain Capital Public Equity Management, LLC | 263,498 | $1,233,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 65,973 | $309,000 | 0.06% |
| Hillhouse Capital Management | 865,923 | $4,053,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 125,151 | $586,000 | 0.04% |
| Marshall Wace North America L.P. | 684,124 | $3,421,000 | 0.02% |
| FNY Partners Fund LP | 20,127 | $94,000 | 0.02% |